Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer.
Xiuwen GuanZongbi YiQiao LiShanshan ChenYing FanJiayu WangYang LuoPin ZhangQing LiBinghe XuPublished in: Signal transduction and targeted therapy (2023)